“DogStem® es el primer y único medicamento registrado con células madre para el tratamiento de perros con osteoartrosis”.

An interview with Sergio Pedrosa, Veterinary Technical Manager of Dômes Pharma for Iberia, is presented. Topics include DogStemis a pioneering product in advanced cell therapy registered in the European Union and the United Kingdom for the treatment of dogs with osteoarthritis (OA); and the DogStem reduces pain and lameness, improves mobility and quality of life for dogs after a single intra-articular injection additional surgery under anesthesia, and a standardized product of veterinary.